Found: 73
Select item for more details and to access through your institution.
EP300 promotes tumor stemness via epigenetic activation of CRISP3 leading to lobaplatin resistance in triple-negative breast cancer.
- Published in:
- Human Cell, 2024, v. 37, n. 5, p. 1475, doi. 10.1007/s13577-024-01091-w
- By:
- Publication type:
- Article
Low NDRG2, regulated by the MYC/MIZ-1 complex and methylation, predicts poor outcomes in DLBCL patients.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 8, p. 2877, doi. 10.1007/s00277-024-05829-2
- By:
- Publication type:
- Article
Gallium complex K6 inhibits colorectal cancer by increasing ROS levels to induce DNA damage and enhance phosphatase and tensin homolog activity.
- Published in:
- MedComm, 2024, v. 5, n. 8, p. 1, doi. 10.1002/mco2.665
- By:
- Publication type:
- Article
Taxane combined with lobaplatin or anthracycline for neoadjuvant chemotherapy of triple-negative breast cancer: a randomized, controlled, phase II study.
- Published in:
- BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03474-0
- By:
- Publication type:
- Article
5-Fluorouracil resistant CRC cells derived exosomes promote cancer-associated fibroblasts secreting more CXCL12.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 11, p. 3441, doi. 10.7150/jca.95248
- By:
- Publication type:
- Article
Metabolomics analysis reveals characteristic metabolites in different levels of oxaliplatin‐induced neurotoxicity.
- Published in:
- Journal of Separation Science, 2024, v. 47, n. 11, p. 1, doi. 10.1002/jssc.202400164
- By:
- Publication type:
- Article
Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer.
- Published in:
- BMC Biotechnology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12896-024-00850-9
- By:
- Publication type:
- Article
Two Hematological Markers Predicting the Efficacy and Prognosis of Neoadjuvant Chemotherapy Using Lobaplatin Against Triple-Negative Breast Cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. e635, doi. 10.1093/oncolo/oyae025
- By:
- Publication type:
- Article
Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis.
- Published in:
- Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01545-6
- By:
- Publication type:
- Article
Multifaceted roles and functions of SOX30 in human cancer.
- Published in:
- Cancer Innovation, 2024, v. 3, n. 2, p. 1, doi. 10.1002/cai2.107
- By:
- Publication type:
- Article
Imaging diagnosis and efficacy monitoring by [<sup>89</sup>Zr]Zr-DFO-KN035 immunoPET in patients with PD-L1-positive solid malignancies.
- Published in:
- Theranostics, 2024, v. 14, n. 1, p. 392, doi. 10.7150/thno.87243
- By:
- Publication type:
- Article
Construction of a ferroptosisbased prognostic model for breast cancer helps to discriminate high/low risk groups and treatment priority.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1264206
- By:
- Publication type:
- Article
A multicenter single‐arm trial of neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2‐positive breast cancer.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.435
- By:
- Publication type:
- Article
Pyrotinib-based therapeutic approaches for HER2-positive breast cancer: the time is now.
- Published in:
- Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-023-01694-5
- By:
- Publication type:
- Article
Correlation between androgen receptor expression and pathological response rate in pre-operative HER2-positive breast cancer patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 12, p. 10109, doi. 10.1007/s00432-023-04904-x
- By:
- Publication type:
- Article
Prognostic Value of Combined LMR and CEA Dynamic Monitoring in Postoperative Colorectal Cancer Patients.
- Published in:
- Journal of Inflammation Research, 2023, v. 16, p. 4229, doi. 10.2147/JIR.S422500
- By:
- Publication type:
- Article
Docetaxel-loaded pH/ROS dual-responsive nanoparticles with self-supplied ROS for inhibiting metastasis and enhancing immunotherapy of breast cancer.
- Published in:
- Journal of Nanobiotechnology, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12951-023-02013-y
- By:
- Publication type:
- Article
Frequent EGFR exon 20 insertion in the so‐called peripheral‐type squamous cell neoplasm of uncertain malignant potential: a variant of bronchiolar adenoma or under‐recognised entity?
- Published in:
- Histopathology, 2023, v. 83, n. 2, p. 178, doi. 10.1111/his.14890
- By:
- Publication type:
- Article
Conventional vs Minimally Invasive Breast Surgery—Reply.
- Published in:
- JAMA Surgery, 2023, v. 158, n. 7, p. 776, doi. 10.1001/jamasurg.2023.0026
- By:
- Publication type:
- Article
Dramatic Response to Pyrotinib and T-DM1 in HER2-Negative Metastatic Breast Cancer With 2 Activating HER2 Mutations.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. e534, doi. 10.1093/oncolo/oyad122
- By:
- Publication type:
- Article
B-Type Natriuretic Peptide Can Distinguish Ischemic Stroke Subtypes Better than Other Cardiac Biomarkers.
- Published in:
- Medical Science Monitor, 2023, v. 29, p. 1, doi. 10.12659/MSM.939829
- By:
- Publication type:
- Article
Investigating the role of FADS family members in breast cancer based on bioinformatic analysis and experimental validation.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1074242
- By:
- Publication type:
- Article
Partitioning and Migration of Trace Elements during Coal Combustion in Two Coal-Fired Power Plants in Hefei City, Anhui Province, Eastern China.
- Published in:
- Minerals (2075-163X), 2023, v. 13, n. 2, p. 152, doi. 10.3390/min13020152
- By:
- Publication type:
- Article
Neoadjuvant checkpoint blockade in combination with Chemotherapy in patients with tripe-negative breast cancer: exploratory analysis of real-world, multicenter data.
- Published in:
- BMC Cancer, 2023, p. 1, doi. 10.1186/s12885-023-10515-z
- By:
- Publication type:
- Article
PIK3CA mutations are associated with pathologic complete response rate to neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancer.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Safety and feasibility assessment of extending the flushing interval in totally implantable venous access port flushing during the non-treatment stage for patients with breast cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1021488
- By:
- Publication type:
- Article
Establishment and validation of a LC–MS/MS method for the determination of anlotinib in human plasma: Application to therapeutic drug monitoring.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 12, p. 1, doi. 10.1002/bmc.5501
- By:
- Publication type:
- Article
Chromobox Family Proteins as Putative Biomarkers for Breast Cancer Management: A Preliminary Study Based on Bioinformatics Analysis and qRT-PCR Validation.
- Published in:
- Breast Cancer: Targets & Therapy, 2022, v. 14, p. 515, doi. 10.2147/BCTT.S381856
- By:
- Publication type:
- Article
Association of Long-term Oncologic Prognosis With Minimal Access Breast Surgery vs Conventional Breast Surgery.
- Published in:
- JAMA Surgery, 2022, v. 157, n. 12, p. e224711, doi. 10.1001/jamasurg.2022.4711
- By:
- Publication type:
- Article
A novel pyroptosis-related indicator of immune infiltration features and prognosis in breast cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.961500
- By:
- Publication type:
- Article
Lobaplatin-based neoadjuvant chemotherapy for triple-negative breast cancer: a 5-year follow-up of a randomized, open-label, phase II trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221107111
- By:
- Publication type:
- Article
Higher Education Teaching Quality Evaluation Model Based on Improved RBF Neural Network.
- Published in:
- Wireless Communications & Mobile Computing, 2022, p. 1, doi. 10.1155/2022/5495728
- By:
- Publication type:
- Article
Sensitive Activatable Nanoprobes for Real‐Time Ratiometric Magnetic Resonance Imaging of Reactive Oxygen Species and Ameliorating Inflammation In Vivo.
- Published in:
- Advanced Materials, 2022, v. 34, n. 19, p. 1, doi. 10.1002/adma.202109004
- By:
- Publication type:
- Article
A Prospective Self-Controlled Study of Indocyanine Green, Radioisotope, and Methylene Blue for Combined Imaging of Axillary Sentinel Lymph Nodes in Breast Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.803804
- By:
- Publication type:
- Article
Development of a Chemiluminescence Assay for Total N-Terminal Propeptide of Type I Collagen and Its Evaluation in Lung Transplantation.
- Published in:
- Journal of Analytical Methods in Chemistry, 2022, p. 1, doi. 10.1155/2022/2711414
- By:
- Publication type:
- Article
Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.770663
- By:
- Publication type:
- Article
Integrated endotoxin-adsorption and antibacterial properties of platelet-membrane-coated copper silicate hollow microspheres for wound healing.
- Published in:
- Journal of Nanobiotechnology, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s12951-021-01130-w
- By:
- Publication type:
- Article
Construction of a Prognostic Risk Prediction Model for Obesity Combined With Breast Cancer.
- Published in:
- Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.712513
- By:
- Publication type:
- Article
Chiral nanomaterials for tumor therapy: autophagy, apoptosis, and photothermal ablation.
- Published in:
- Journal of Nanobiotechnology, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s12951-021-00965-7
- By:
- Publication type:
- Article
Serum Chemokine CXCL7 as a Potential Novel Biomarker for Obstructive Colorectal Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.599363
- By:
- Publication type:
- Article
Neoadjuvant Pyrotinib plus Trastuzumab and Chemotherapy for Stage I–III HER2‐Positive Breast Cancer: A Phase II Clinical Trial.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1909, doi. 10.1002/onco.13546
- By:
- Publication type:
- Article
Clinical and Prognostic Relevance of B7-H3 and Indicators of Glucose Metabolism in Colorectal Cancer.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.546110
- By:
- Publication type:
- Article
Sialidase NEU1 suppresses progression of human bladder cancer cells by inhibiting fibronectin-integrin α5β1 interaction and Akt signaling pathway.
- Published in:
- Cell Communication & Signaling, 2020, v. 18, n. 1, p. 1, doi. 10.1186/s12964-019-0500-x
- By:
- Publication type:
- Article
SPZ1 promotes deregulation of Bim to boost apoptosis resistance in colorectal cancer.
- Published in:
- Clinical Science, 2020, v. 134, n. 2, p. 155, doi. 10.1042/CS20190865
- By:
- Publication type:
- Article
A 21-gene Support Vector Machine classifier and a 10-gene risk score system constructed for patients with gastric cancer.
- Published in:
- Molecular Medicine Reports, 2020, v. 21, n. 1, p. 347, doi. 10.3892/mmr.2019.10841
- By:
- Publication type:
- Article
Serum Chemokine CXCL7 as a Diagnostic Biomarker for Colorectal Cancer.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00921
- By:
- Publication type:
- Article
Prognostic nomogram based on immune scores for breast cancer patients.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 11, p. 5214, doi. 10.1002/cam4.2428
- By:
- Publication type:
- Article
hsa_circRNA_0006528 as a competing endogenous RNA promotes human breast cancer progression by sponging miR‐7‐5p and activating the MAPK/ERK signaling pathway.
- Published in:
- Molecular Carcinogenesis, 2019, v. 58, n. 4, p. 554, doi. 10.1002/mc.22950
- By:
- Publication type:
- Article
Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer.
- Published in:
- International Journal of Cancer, 2019, v. 144, n. 2, p. 281, doi. 10.1002/ijc.31601
- By:
- Publication type:
- Article
Med19 is involved in chemoresistance by mediating autophagy through HMGB1 in breast cancer.
- Published in:
- Journal of Cellular Biochemistry, 2019, v. 120, n. 1, p. 507, doi. 10.1002/jcb.27406
- By:
- Publication type:
- Article